Brief: Biomaxima Files For Registration Of SARS-CoV-2 Antibody Rapid Test
March 12 (Reuters) - BioMaxima SA BMX.WA :
* SAYS FILES FOR REGISTRATION TEST FOR DETECTING SARS-COV-2
ANTIBODIES
* SAYS AFTER 14 DAYS FROM FILING FOR REGISTRATION IT WILL
GET THE
RIGHT TO SELL TEST IN POLAND
Source text for Eikon: ID:nEM4Qwsfja
Further company coverage: BMX.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on BioMaxima SA
See all newsBrief: Biomaxima Q1 Net Profit 0.3 Million Zlotys
Brief: Biomaxima Project On Mic Gradient Strip Tests Selected For Funding
Brief: BioMaxima Signs 0.5 Mln Zloty Deal With Hospital In Opole
Brief: BioMaxima Unit Signs 1-Year Supply Contract With Hospital In Romania
Brief: BioMaxima Signs 0.7 Mln Zloty Deal For Microbiological Media Supply